NEW YORK (GenomeWeb News) — Stem cell therapeutics and research tools firm StemCells said today that it has transferred the Melbourne, Australia-based operations of recently acquired Stem Cell Sciences to StemCells' facilities in Cambridge, UK, and Palo Alto, Calif.

The move is part of StemCells' efforts to streamline operations following its estimated $4.8 million acquisition of SCS, which it originally announced in March and closed on April 1.